Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts PARSIPPANY, NJ, July 29, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today responded to the undefined...

Seniors Struggling with Depression Not Using Medicare Mental Health Benefits While seniors minimize exposure to the outside world to mitigate exposure to Coronavirus, there is a trade-off of physical wellness and mental health that is being observed in the senior...